Pan S, Wang N, Bisetto S, Yi B, Sheu SS. Downregulation of adenine nucleotide translocator 1 exacerbates tumor necrosis factor-␣-mediated cardiac inflammatory responses. Am J Physiol Heart Circ Physiol 308: H39 -H48, 2015. First published November 7, 2014 doi:10.1152/ajpheart.00330.2014.-Inflammation contributes significantly to cardiac dysfunction. Although the initial phase of inflammation is essential for repair and healing, excessive proinflammatory cytokines are detrimental to the heart. We found that adenine nucleotide translocator isoform-1 (ANT1) protein levels were significantly decreased in the inflamed heart of C57BL/6 mice following cecal ligation and puncture. To understand the molecular mechanisms involved, we performed small-interfering RNA-mediated knockdown of ANT1 and studied tumor necrosis factor-␣ (TNF␣)-induced inflammatory responses in myocardium-derived H9c2 cells and cardiomyocytes. ANT1 knockdown significantly increased swollen mitochondria and mitochondrial reactive oxygen species, concomitant with increased TNF␣-induced NF-B reporter gene activity and interleukin-6 and TNF␣ expression. A mitochondrial-targeted antioxidant mito-TEMPO attenuated TNF␣-induced mitochondrial reactive oxygen species, NF-B reporter gene activity, and cytokine expression in ANT1 knockdown cells. Interestingly, TNF␣ or lipopolysaccharide (LPS) treatment significantly decreased ANT1 protein levels, suggesting a feed-forward regulation of proinflammatory cytokine expression activated by ANT1 downregulation. These data suggest that ANT1 downregulation contributes to cardiac inflammation postcecal ligation and puncture. Preventing ANT1 downregulation could provide a novel molecular target to temper cardiac inflammation. adenine nucleotide translocator; cytokine; inflammation; sepsis MYOCARDIAL DYSFUNCTION is the predominant cause of death in severe septic patients. Approximately 60% of patients admitted to the intensive care units present cardiac dysfunction and, more importantly, with mortality rates up to 90% (6, 37, 51) . Although the underlying mechanisms for sepsis-induced cardiac depression are complex and not well understood, recent studies demonstrate that proinflammatory cytokines play a crucial role (24, 29, 39) . Inflammation is initially beneficial to coordinating defense and repair. However, excessive production of proinflammatory cytokines is detrimental to the heart (25).
MYOCARDIAL DYSFUNCTION is the predominant cause of death in severe septic patients. Approximately 60% of patients admitted to the intensive care units present cardiac dysfunction and, more importantly, with mortality rates up to 90% (6, 37, 51) . Although the underlying mechanisms for sepsis-induced cardiac depression are complex and not well understood, recent studies demonstrate that proinflammatory cytokines play a crucial role (24, 29, 39) . Inflammation is initially beneficial to coordinating defense and repair. However, excessive production of proinflammatory cytokines is detrimental to the heart (25) .
In septic patients, TNF␣ is the prime mediator of the inflammatory response (47) . It serves as an essential element of host defense. Moreover, it evokes the immune responses by inducing the production of a cascade of proinflammatory cytokines. Particularly, increased TNF␣ and IL-6 levels are associated with worse outcomes (17, 46, 50) . Although originally TNF␣ and IL-6 were found to be secreted by activated neutrophils and macrophages, recent studies have demonstrated that cardiac cells produce these proinflammatory cytokines as well, suggesting that localized inflammatory cytokine plays a role in inflammation-induced cardiac dysfunction (20, 22) .
We have recently demonstrated that ADP is protective to the opening of the mitochondrial permeability transition pore in the heart under pathological conditions, and adenine nucleotide translocator (ANT) is indispensable for its protection (45) . ANT isoform 1 (ANT1) is the predominant ANT isoform in the heart. It drives the exchange of ADP/ATP between cytosol and mitochondria, using the electrochemical gradient (40, 41) . Transgenic expression of ANT1 is protective to the heart (52) (53) (54) . In contrast, ANT1 deficiency is associated with cardiac dysfunction (18, 27, 28, 32-34, 40, 48) . Interestingly, recent studies have found that ANT1 is dysregulated in myocarditis and dilated cardiomyopathy (11) (12) (13) . However, the mechanistic role of ANT1 in inflammation has not been elucidated.
In the present study, we investigated the role of ANT1 in TNF␣-induced inflammatory response. Our data suggest that ANT1 downregulation is likely a key contributor to exacerbate cardiac inflammation at least partly through increasing inflammatory cytokine expression.
were then resuscitated with 1 ml of saline injected subcutaneously. Sham-operated controls were treated in an identical manner but without ligation and puncture. Survival was monitored every day for 72 h. Data were analyzed by log rank test using the statistical package R.
In vivo echocardiography. Transthoracic two-dimensional echocardiography was performed by using echocardiographic imaging system (Vevo 2100, VisualSonic, Toronto, Canada) with a 40-MHz probe. Mice were anesthetized through the inhalation of isoflurane (ϳ1-2%). M-mode interrogation was performed in the parasternal short-axis view at the level of the greatest left ventricular end-diastolic dimension. Left ventricular wall thickness and internal dimensions were measured and used for calculation. Fraction shortening and ejection fraction values were exported from the echo program.
Cell culture, siRNA oligonucleotide treatment, and adenovirus infection. Myocardial myoblast H9c2 cells were purchased from ATCC and cultured in Dulbecco's modified Eagle's medium with 10% fetal bovine serum (Gibco, Grand Island, NY). Cells at passages 5-15 were used for experiments. Rat neonatal cardiomyocytes were isolated and cultured as previously described (7) . To knock down ANT1, cells were treated with ANT1 siRNA. RNAiMAX (Life Technologies) was used according to the instructions of the manufacturer. Adenoviruses harboring mouse ANT1 were used to infect H9c2 cells as previously described (2) .
Western blot analysis. Western blots analysis (immunoblots) were performed as previously described (35, 36) . The images were acquired and analyzed by Licor Odyssey system. Equal loading of protein was ensured by measuring tubulin expression.
Quantitative real-time PCR. Qualitative real-time PCR was performed on iCycler iQ5 system using SYBR green (Bio-Rad). The primer sequences are as follows: TNF␣, 5=-cccagaccctcacactcagat-3= and 5=-ttgtcccttgaagagaacctg-3=; IL-6, 5=-tcaactccatctgcccttcag-3= and 5=-aaggcaactggctggaagtct-3=; and 18S, 5=-tcaagaacgaaagtcggagg-3= and 5=-ggacatctaagggcatcaca-3=.
Reporter gene assay. Reporter gene and ␤-galactosidase activity assays were performed following the manufacturer's instructions. Briefly, cells cotransfected with reporter gene construct, together with ␤-galactosidase construct, were treated with TNF␣ (10 ng/ml) for 18 h and harvested 48 h after transfection. Luciferase activity was measured following the manufacturer's instructions. Data were normalized using ␤-galactosidase activity as the internal control.
Confocal and mitochondrial function assay. Cells were loaded with MitoTracker Green, MitoSox Red, or tetramethylrhodamine ethyl ester following the manufacturer's instructions. Mitochondria images were acquired by Flouview (Olympus) using a ϫ60 oil objective and analyzed using National Institutes of Health ImageJ (v. 1.44). Oxygen consumption was measured using clark electrode as previously described (45) . Respiration control ratio was determined by stages 3 and 4 oxygen consumption.
Statistical analysis. Results represent at least three independent experiments if not mentioned specifically, and data are expressed as means Ϯ SE. Where indicated, ANOVA was performed. One-way ANOVA was used for multiple group analysis, and paired Student's t-test was used for the comparison between two groups. P Ͻ 0.05 was considered significant in all experiments.
RESULTS
ANT1 is downregulated in the inflamed heart. To understand the role for ANT1 in cardiac inflammation, we performed cecal ligation and puncture (CLP) in mice. Percent survival was significantly decreased after 24 h of CLP, likely because of CLP-induced organ failure (Fig. 1A) . Therefore, we focused our studies on the initial 24-h post-CLP during which time inflammation was dominant. At 24 h, cardiac performance was significantly lower than that in sham-operated mice. The ejection fraction decreased from 66.1 Ϯ 3.7 to 45.9 Ϯ 18.5% (P Ͻ 0.05) and fraction shortening decreased from 35.6 Ϯ 4.9% to 25.7 Ϯ 16.9% (P Ͻ 0.05) as measured by echocardiography (Fig. 1, B and C) . There was no significant change in heart rate at this 24 h time point (Fig. 1D ). There was an ϳ50% decrease in cardiac output (Fig. 1E) .
ANT1 protein levels were significantly decreased in the left ventricle of CLP mice at 24 h as assessed by Western blot ( Fig.  2A) . Protein extracts from liver were used as the control for antibody specificity (the ANT1 antibody detects only ANT1 in the heart, but not ANT2 in the liver) ( Fig. 2A) . In the heart, ANT1 decreased to 50% of sham at 24 h after CLP (Fig. 2B ). In contrast, there was no significant difference in mitochondrial matrix protein CypD between sham and 24 h after CLP (Fig. 2 , C and D). These data demonstrate that ANT1 is downregulated in the heart post CLP. Protein levels of vascular cell adhesion molecule-1, one of the indicators of inflammation, was increased ϳ2.4-fold at 24 h post CLP (Fig. 2, E and F) .
ANT1 knockdown results in a reduction of mitochondrial respiration ratio and an increase in mitochondrial membrane potential in myocardium-derived H9c2 cells. To understand the effect of ANT1 downregulation on mitochondrial function, we performed siRNA studies to knock down ANT1 in H9c2 cells. ANT1 siRNA decreased ANT1 protein levels to 40% of control cells (Fig. 3, A and B) without affecting other mito- chondrial proteins such as CypD (Fig. 3A, bottom) and voltagedependent anion channel (data not shown). Mitochondrial respiration control ratio was decreased by ANT1 knockdown (from 7.4 Ϯ 14.9% to 2.6 Ϯ 18%, P Ͻ 0.05) (Fig. 3C ). In addition, mitochondrial membrane potential was ϳ1.3-fold higher in ANT1 knockdown cells (Fig. 3D) .
ANT1 knockdown increases swollen and donut/blob-shaped mitochondria in H9c2 cells. During sepsis, there is a marked and rapid increase in TNF␣ followed by other proinflammatory cytokines (38, 47) . Therefore, to understand the meaning of ANT1 downregulation in inflammation, we studied TNF␣-induced immune responses in ANT1 knockdown H9c2 cells.
We first studied the effect of ANT1 knockdown on TNF␣-induced mitochondrial morphological changes by live cell confocal imaging. To compare mitochondrial morphology objectively among different groups of cells, individual mitochondria were measured in high magnification. Mitochondria are tubular under normal conditions but change to a donut shape under mild stress and to a blob shape under high stress (1). Control siRNA-transfected cells primarily displayed tubular and long mitochondria. The mitochondria form networks and spread throughout the cells (Fig. 4A) . In contrast, ANT1 knockdown cells displayed an increased proportion of swollen and donut/blob-shaped mitochondria (Fig. 4C) .
Because TNF␣ treatment causes the formation of donut/ blob-shaped mitochondria (1), we next quantified whether ANT1 knockdown would favor TNF␣-induced donut/blobshaped mitochondria formation. In control siRNA-transfected cells, TNF␣ treatment significantly increased the percentage of donut/blob-shaped mitochondria (from 5.1 Ϯ 0.2 to 14.4 Ϯ 0.1, P Ͻ 0.05) (Fig. 4, B and E) . Interestingly, ANT1 knockdown further increased donut/blob-shaped mitochondria (Fig.  4, C-E) . In ANT1 knockdown cells, the percentage of donut/ blob-shaped mitochondria was significantly increased after TNF␣ treatment (to 29.3 Ϯ 0.05, P Ͻ 0.01 vs. matched control siRNA group), indicating that ANT1 knockdown sensitizes mitochondria to stress/TNF␣-induced morphological changes (Fig. 4, C-E) .
ANT1 knockdown increases mitochondrial reactive oxygen species generation in H9c2 cells. We next examined whether ANT1 knockdown increases mitochondrial reactive oxygen species (mtROS) because TNF␣ treatment induces mtROS generation (9) . In control siRNA-transfected cells, TNF␣ treatment caused an ϳ2.0-fold increase in mtROS as indicated by the increased MitoSox Red fluorescent intensity (Fig. 5, A, B , and E). ANT1 knockdown alone (vehicle treatment) increased mtROS by ϳ2.0-fold (Fig. 5, C-E) . Moreover, there was an ϳ5.0-fold increase in mtROS in ANT1 knockdown cells treated with TNF␣ (Fig. 5, D and E) . Our data indicate that ANT1 downregulation promotes mtROS generation in H9c2 cells.
ANT1 knockdown increases TNF␣-induced NF-B reporter gene activity and IL-6 and TNF␣ expression in H9c2 cells.
In both human patients and rodent models of sepsis, inflammation is associated with significant increases in ROS generation, NF-B activation, and inflammatory cytokine production (3, 17, 42, 46, 50) . Therefore, we next determined whether ANT1 modulates NF-B reporter gene activity in response to TNF␣.
In control siRNA-transfected cells, TNF␣ significantly increased NF-B luciferase activity (from 19.7 Ϯ 1.3 to 386.3 Ϯ 1.7, P Ͻ 0.01) (Fig. 6A ). More importantly, ANT1 knockdown further increased TNF␣-induced NF-B reporter gene activity (to 817.9 Ϯ 1.3, P Ͻ 0.01 vs. TNF␣-treated control group), suggesting that ANT1 knockdown enhances TNF␣-induced NF-B activation (Fig. 6A) .
The role of ANT1 in NF-B activation was further confirmed by infecting cells with either control adenovirus (Ad-LacZ) or mouse ANT1 adenovirus (Ad-ANT1) (Fig. 6B ) (4). In control virus-transfected cells, TNF␣ significantly increased NF-B luciferase activity (from 34.9 Ϯ 3.1 to 748.9 Ϯ 55.7, P Ͻ 0.01). More importantly, ANT1 overexpression significantly reduced TNF␣-induced NF-B luciferase activity (to 506.1 Ϯ 39.7, P Ͻ 0.01 vs. TNF␣-treated control group) (Fig. 6B) , supporting a positive role for ANT1 downregulation in TNF␣-induced NF-B activation.
During inflammation, TNF␣ is the prime mediator of the inflammatory response and triggers the expression of other cytokines (47) . Because TNF␣ and IL-6 are transcriptionally regulated by NF-B, we next determined the effect of ANT1 knockdown on the expression of IL-6 and TNF␣ in H9c2 cells (Fig. 6, C and D) . There was an ϳ2.1-fold increase in endogenous IL-6 mRNA levels by ANT1 knockdown alone (plus vehicle treatment). Moreover, the combination of ANT1 knockdown and exogenous TNF␣ further caused an ϳ3.6-fold increase in IL-6 mRNA (Fig. 6C) . Similarly, ANT1 knockdown caused an ϳ1.97-fold and an ϳ10.1-fold increase in TNF␣ mRNA levels in vehicle-and recombinant TNF␣-treated cells, respectively (Fig. 6D) . Success in ANT1 knockdown or overexpression was confirmed by Western blot analysis (Fig. 6, E and F) .
MTP attenuates mtROS generation, TNF␣-induced NF-B reporter gene activity, and IL-6 and TNF␣ expression in ANT1
knockdown cells. Because ANT1 knockdown increases mtROS generation (Fig. 5) , we first determined whether mitochondrialtargeted antioxidant MTP would attenuate mtROS generation in control and ANT1 knockdown cells in response to vehicle or TNF␣ (Fig. 7A) . In control siRNA group treated with MTP, no significant change was detected in vehicle-treated cells. However, MTP significantly decreased TNF␣-induced mtROS (from 1.5 Ϯ 0.03 to 0.9 Ϯ 0.02, P Ͻ 0.05). In ANT1 knockdown group, MTP decreased mtROS in vehicle-treated cells (from 1.9 Ϯ 0.03 to 0.9 Ϯ 0.02, P Ͻ 0.05). More dramatic decrease of mtROS by MTP was found in TNF␣-treated ANT1 knockdown cells (from 2.5 Ϯ 0.02 to 0.8 Ϯ 0.05, P Ͻ 0.05) (Fig. 7A) . We next determined whether mtROS plays a role in TNF␣-induced NF-B activation in control and ANT1 knockdown H9c2 cells (Fig. 7B) . In control siRNA group treated with MTP, TNF␣-induced NF-B reporter gene activity was significantly decreased (from 1508.2 Ϯ 18.9 to 1158.9 Ϯ 42.2, P Ͻ 0.05). More dramatic changes of TNF␣-induced NF-B reporter gene activity were found in ANT1 knockdown groups treated with MTP (from 3630.4 Ϯ 184.9 to 2149.7 Ϯ 80.7, P Ͻ 0.05) (Fig. 7B) .
We further determined whether MTP reduces TNF␣-induced IL-6 and TNF␣ expression after ANT1 knockdown in H9c2 cells (Fig. 7, C and D) . ANT1 knockdown increased TNF␣-induced IL-6 and TNF␣ expression as we previously observed. MTP had little effect on the expression of IL-6 and TNF␣ in vehicle-treated control siRNA or ANT1 siRNA groups (MTP group vs. control group) (Fig. 7, C and  D) . However, in TNF␣-treated cells, MTP decreased IL-6 expression in control siRNA groups (from ϳ2.3 Ϯ 0.07 to 0.8 Ϯ 0.003, P Ͻ 0.05) (Fig. 7C) . More importantly, MTP decreased IL-6 expression in ANT1 siRNA groups treated with TNF␣ (from 3.5 Ϯ 0.14 to 1.2 Ϯ 0.01, P Ͻ 0.05) (Fig.  7C) . Similarly, MTP decreased TNF␣ expression in control Fig. 7 . mito-TEMPO (MTP) reduces mtROS generation, TNF␣-induced NF-B activation, and IL-6 and TNF␣ expression. A: mtROS generation. ANT1 knockdown, and control H9c2 cells were preincubated with 10 nM MTP for 1 h before being exposed to 10 ng/ml TNF␣ for 24 h. mtROS generation was measured by MitoSox Red fluorescence. Data were from 3 independent experiments. *P Ͻ 0.05 vs. control siRNA treated with vehicle; **P Ͻ 0.05 vs. ANT1 siRNA treated with vehicle; #P Ͻ 0.05 vs. control siRNA treated with TNF␣; ##P Ͻ 0.05 vs. ANT1 siRNA treated with TNF␣. B: NF-B luciferase reporter gene activity. ANT1 knockdown and control H9c2 cells were transfected with NF-B luciferase reporter gene plasmid and ␤-galactosidase plasmid as the internal control. Cells were preincubated with 10 nM MTP for 1 h before being exposed to 10 ng/ml TNF␣ for 18 h. Data were from 3 independent experiments normalized by ␤-galactosidase activity. *P Ͻ 0.05 vs. control siRNA treated with vehicle; **P Ͻ 0.05 vs. control siRNA treated with TNF␣; #P Ͻ 0.05 vs. control siRNA treated with TNF␣; ##P Ͻ 0.05 vs. ANT1 siRNA treated with TNF␣. IL-6 (C) and TNF␣ (D) expression in H9c2 cells. Control and ANT1 knockdown cells were preincubated with 10 nM MTP for 1 h before TNF␣ treatment for 8 h (10 ng/ml). IL-6 and TNF␣ expression were examined by quantitative real-time PCR analysis. Data were from 3 independent experiments normalized to control siRNA with vehicle treatment. *P Ͻ 0.05 vs. control siRNA treated with vehicle; **P Ͻ 0.05 vs. control siRNA treated with TNF␣; #P Ͻ 0.05 vs. control siRNA treated with TNF␣; ##P Ͻ 0.05 vs. ANT1 siRNA treated with TNF␣. IL-6 (E) and TNF␣ (F) expression in rat neonatal cardiomyocytes. Control and ANT1 knockdown cardiomyocytes were preincubated with 10 nM MTP for 1 h before TNF␣ treatment for 8 h (10 ng/ml). IL-6 and TNF␣ expression were examined by quantitative real-time PCR analysis. Data were from 3 independent experiments normalized to control siRNA with vehicle treatment are shown. *P Ͻ 0.05 vs. control siRNA treated with vehicle; **P Ͻ 0.05 vs. control siRNA treated with TNF␣; #P Ͻ 0.05 vs. control siRNA treated with TNF␣; ##P Ͻ 0.05 vs. ANT1 siRNA treated with TNF␣.
siRNA groups treated with exogenous TNF␣ (from 3.7 Ϯ 0.13 to 1.7 Ϯ 0.01, P Ͻ 0.05) (Fig. 7D) . Moreover, MTP dramatically decreased TNF␣ expression in ANT1 siRNA groups treated with exogenous TNF␣ (from 9.7 Ϯ 0.88 to 1.7 Ϯ 0.02, P Ͻ 0.05) (Fig. 7D) .
The effect of MTP on IL-6 and TNF␣ expression was further confirmed using isolated cardiomyocytes (Fig. 7, E and F) . ANT1 knockdown increased TNF␣-induced IL-6 and TNF␣ expression (to 3.8 Ϯ 0.4, P Ͻ 0.05, and 3.6 Ϯ 0.3, P Ͻ 0.05, respectively) ( Fig. E and F) . MTP had little effect on the expression of IL-6 and TNF␣ in vehicle-treated control siRNA or ANT1 siRNA groups (MTP group vs. control group) (Fig. E  and F) . However, in TNF␣-treated cells, MTP decreased IL-6 expression in control siRNA groups (from 1.4 Ϯ 0.3 to 1.2 Ϯ 0.3, P Ͻ 0.05) (Fig. 7E ). More importantly, MTP significantly decreased IL-6 expression in ANT1 siRNA groups treated with TNF␣ (from 3.8 Ϯ 0.4 to 1.1 Ϯ 0.5, P Ͻ 0.05) (Fig. 7E) . Similarly, MTP decreased TNF␣ expression in control siRNA groups treated with exogenous TNF␣ (from 1.6 Ϯ 0.4 to 1.2 Ϯ 0.3, P Ͻ 0.05) (Fig. 7F) . Moreover, MTP dramatically decreased TNF␣ expression in ANT1 siRNA groups treated with exogenous TNF␣ (3.6 Ϯ 0.3 to 1.1 Ϯ 0.3, P Ͻ 0.05) (Fig. 7F) . Taken together, our data support a role for mtROS in TNF␣-induced NF-B activation and proinflammatory cytokine expression after ANT1 knockdown.
TNF␣ or LPS treatment decreases ANT1 protein levels in H9c2 cells. We found that ANT1 is downregulated in the inflamed heart of CLP mice (Fig. 2) . Because CLP significantly increases inflammatory cytokines, we investigated whether inflammatory cytokines per se could induce ANT1 downregulation. We assayed the effect of recombinant TNF␣ and LPS on ANT1 protein levels in H9c2 cells (Fig. 8) . Indeed, TNF␣ decreased ANT1 protein levels in a dose-dependent manner (to 78% at 10 ng/ml and to 66.7% at 50 ng/ml) (Fig. 8, A and B) . Similarly, ANT1 protein levels were significantly decreased by LPS treatment (to 72%) (Fig. 8, C and D) .
DISCUSSION
In the present study, we provide a novel target for mitochondrial regulation of cardiac inflammation. We found that ANT1 protein levels were significantly downregulated in the inflamed heart in our murine model of systemic inflammation induced by CLP. Characterization of mitochondria in ANT1 knockdown cells indicated a decrease in mitochondrial respiration control ratio, an increase in mitochondrial membrane potential and mtROS generation. Further mechanistic studies support a role for mtROS in ANT1 downregulation-induced inflammatory response, because mitochondria-targeted antioxidant MTP reduced NF-B reporter gene activity, as well as IL-6 and TNF␣ expression stimulated by recombinant TNF␣. These data are consistent with previous observations that TNF␣ causes the formation of donut/blob-shaped mitochondria and are supported by the finding that ANT1 negatively regulates ROS generation (1, 14, 23) . Interestingly, TNF␣ and LPS treatments that mimic the environment in inflamed cells in turn decreased ANT1 protein levels, implicating a feed-forward regulation of inflammatory cytokine production mediated by ANT1 downregulation.
Our data support a model in which increased production of TNF␣ during CLP triggers ANT1 downregulation in the heart. In turn, ANT1 downregulation exacerbates TNF␣-induced NF-B activation and TNF␣ and IL-6 expression, leading to excessive inflammation in the heart (Fig. 8E) .
During inflammation, immune factors such as cytokines and chemokines are secreted to coordinate defense and repair. However, excessive proinflammatory cytokines cause cellular and mitochondrial damage. In septic patients, one of the most severe and frequent complications is inflammation-induced cardiac dysfunction. Its presence is associated with significantly increased mortality rates (6, 31, 37, 51) . Although the molecular mechanisms for sepsis-induced cardiac dysfunction are complicated and not completely understood, a growing body of evidence indicates that increased inflammatory cytokine production contributes significantly to its pathogenesis (21, 30) . Similarly, a sustained increase in TNF␣ or IL-6 has also been reported in several pathological processes, such as ischemic myocardial injury, cardiac hypertrophy, myocardial infarction, and chronic heart failure (5, 15, 19, 26, 49) .
We demonstrate that ANT1 downregulation enhances TNF␣-induced NF-B reporter gene activity. In septic patients, NF-B is a critical indicator for survival because NF-B activity is significantly higher in nonsurvivors and correlates strongly with the severity of the illness (3). The pathological role of NF-B activation is also supported by the finding that inhibiting NF-B prevents CLP-induced organ dysfunction and reduces cardiac hypertrophy and heart failure (8, 19) . Interestingly, our data support a role for ANT1 downregulation in mtROS-mediated NF-B activation. Because sepsis-induced organ failure is associated with increased NF-B activation and oxidative damage induced by mitochondrial dysfunction (10, 16) , preventing ANT1 downregulation could be beneficial, diminishing mtROS generation and NF-B activation.
Studies to date indicate that mitochondria participate in the detection of microorganisms and cellular damage to activate innate immune responses (43, 44) . Here, we provide further evidence for ANT1 modulation of cardiac inflammation and assert the importance of cross talk between mitochondrial proteins and cytosolic pathways in the regulation of inflammation. Our data suggest that ANT1 downregulation, NF-B activation, and subsequent inflammatory cytokine production form a vicious cycle that exacerbates inflammation. Although how much of an effect increasing myocardial ANT1 would have in CLP mice is still not clear at this point. ANT1 downregulation could be a novel molecular target in sepsisinduced cardiac inflammation, especially since mitochondrial mass and protein synthesis do not change during sepsis (16) . Further studies on the regulatory mechanisms of ANT1 will shed light on its role in preventing excessive inflammation.
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